Experiences of those offered CLS: promotion of treatment uptake
Experiences of children and their families offered Hybrid Closed Loop System technology: what promotes treatment uptake?
Liverpool John Moores University
Duration of Study in the UK
0 years, 6 months, 0 days
The research asks what promotes uptake of a Hybrid Closed Loop Insulin Delivery System, as part of a pilot trial, within a paediatric diabetes population. It aims to explore the experiences of young people with type 1 diabetes, and their families, when offered Closed Loop System (CLS) technology by health professionals. The study aims to explore experiences of how the technology was offered to patients, and whether this resulted in uptake of a CLS. Exploring ‘what works’ when health professionals offer the CLS, aims to highlight what is important to patients and their families when deciding to adopt life-changing diabetes technology. Knowing what promotes current uptake of a CLS can support health professionals to promote future uptake of the technology. By increasing uptake of CLS technology, may then lead to an improvement of overall diabetes management and quality of life across paediatric populations and their families.
The study will take place within a paediatric diabetes team in Southport and Ormskirk Hospital NHS Trust consisting of semi-structured qualitative interviews. The interviews will run over a period of 3 months and consist of 4 or 5 semi-structured questions, lasting no more than 1 hour for each interview. Participation in the interviews will be offered to all patients, and their families, who have been offered the CLS technology, regardless of whether uptake of the technology was accepted or declined.
East Midlands - Derby Research Ethics Committee
Date of REC Opinion
6 Jun 2023
Further Information Favourable Opinion